Lorem ipsum dolor sit amet
Our premium IVs can be helpful to those who require regular IV fluids or medication due to chronic health conditions. In addition, some patients also require short-term injections and fluids after surgery. Our IV vitamins rejuvenate, detox, and hydrate and are absorbed at a rate of 100%, unlike oral supplements.
Our patients, with the supervision and consultation of the general physician, can receive the following IV drips, fluids, and medication.
Junaid is the Chief Medical Scientist at Microsoft Research and a practicing physician in the NHS (United Kingdom National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care. He co-founded “VelocityHealth” as Europe’s first prevention-focused digital-health accelerator, in partnership with Telefonica. Previously, Junaid has worked across primary care, secondary care, and public health settings, in addition to acting as a player, and policymaker within the UK, where he specialized in informatics, digital transformation, and leadership. Junaid hopes to unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.
Dr. Suhail Chughtai , a fellow of Royal College of Surgeons, UK, has various professional roles such as o rthopaedic surgeon based in London, medico- legal examiner, tele- health speaker and expert alongside being a creative medical software designer. He has over 20 years of experience in orthopaedics and trauma in the capacity of a consultant and his work in the field of telemedicine has been awarded by several notable organizations such as Commonwealth Digital Healthcare Awards among many others. He is Chief Technology Offer at THB.
Dr. Jared D. Ament is a fellowship-trained American board-certified neurosurgeon.
He specializes in complex and minimally invasive brain and spine surgery, using the latest technologies, including neuronavigation and robotics. His practice focuses heavily on motion preservation, expanding the frontier in both cervical and lumbar artificial disc replacement surgeries.
Dr. Ament has operated on many celebrities and professional athletes and is currently the Principal Investigator on several FDA clinical trials, researching to next generation of artificial disc and motion preservation technologies. Dr. Ament received his Hon. BSc. from the University of Toronto and his MD from the Medical School for International Health, a collaborative initiative between Ben-Gurion University in Israel and Columbia University, New York.
Professor Firas R. Alani, MD, is a Consultant Cardiologist at the American Hospital Dubai. He joined the American Hospital in September 2019 and comes with a 12-year USA experience In the field of Cardiology.
He Is served as Chief Medical Director of the Heart and Vascular Center at the American Hospital Dubai and is currently the Chairman of the American Hospital Academic Institution (AHAI). He was awarded the “Golden Stethoscope” award in teaching at the Drexel University College of Medicine.
He completed his fellowship in Cardiovascular medicine and Interventional Cardiology at the esteemed Drexel university in Philadelphia, Pennsylvania. He was elected as Chief Fellow during his Interventional Cardiology Fellowship. Dr. Alani completed a six-month Fellowship in Advanced Structural Heart Disease at the Henry Ford Hospital in 2018.
Dr. Alani obtained American Board Certifications in six different medical disciplines. He is certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Nuclear Cardiology, Vascular Medicine, and Endovascular Interventions. He also carries the certification of the United States Registered Physician in Vascular Interpretation (RPVI). He was the co-director of the Cardiopulmonary Course At the Medical School for 6 years.
Dr. Alani was granted the full rank of Professorship in Cardiovascular Medicine from the CMU College of Medicine in April 2019.
He was the primary Principal Investigator on more than 20 International Clinical Trials and has published more than 40 articles in well-respected peer-review medical journals. He is a well-known national and international speaker and was invited to speak in multiple conferences across the globe.
Dr. Firas Alani’s passion is to provide the best healthcare care to all his patients and the patients of the Heart and Vascular Center with the cutting-edge medical knowledge and technology available.
He specializes in complex coronary interventions and structural heart disease interventions with experience in most advanced therapies in valvular heart disease such TAVR and TMVR (replacement of Heart valves using minimal invasive technologies and avoiding open heart surgeries. He is very passionate about teaching and has dedicated a large portion of his career training young scholars from different levels and background to become successful physicians of the future.